Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

To participate, please dial one of the following numbers and ask to join the Verona Pharma call: For further information please contact: Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. OhtuvayreTM (ensifentrine) is the Company's first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-stero ...